CN Stock MarketDetailed Quotes

600867 Tonghua Dongbao Pharmaceutical

Watchlist
  • 10.03
  • -0.12-1.18%
Market Closed Apr 19 15:00 CST
20.00BMarket Cap17.12P/E (TTM)

Tonghua Dongbao Pharmaceutical Key Stats

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
(Q9)Sep 30, 2021
Total operating revenue
10.69%3.08B
-0.36%2.09B
-1.53%1.37B
-25.03%665.36M
-14.98%2.78B
-14.50%2.1B
-16.53%1.39B
7.85%887.48M
12.99%3.27B
12.33%2.46B
Operating revenue
10.69%3.08B
-0.36%2.09B
-1.53%1.37B
-25.03%665.36M
-14.98%2.78B
-14.50%2.1B
-16.53%1.39B
7.85%887.48M
12.99%3.27B
12.33%2.46B
Other operating revenue
299.83%145.81M
----
7.32%16.63M
----
-25.90%36.47M
----
9.95%15.5M
----
32.54%49.22M
----
Total operating cost
-5.64%1.77B
-8.82%1.26B
-9.45%832.24M
-10.14%394.62M
-6.05%1.88B
-3.74%1.39B
0.35%919.07M
1.54%439.14M
10.89%2B
8.39%1.44B
Operating cost
-0.77%612.77M
-1.64%443.41M
-0.01%306.83M
-0.94%149.05M
7.27%617.51M
2.47%450.79M
1.97%306.87M
5.10%150.47M
-2.16%575.65M
-4.60%439.91M
Operating tax surcharges
-3.64%14.04M
-15.54%10.39M
-25.30%6.32M
-12.36%3.84M
29.33%14.57M
3.94%12.3M
12.55%8.46M
1.69%4.39M
-1.81%11.27M
6.49%11.84M
Operating expense
-2.22%912.83M
-7.71%633.67M
-12.48%399.25M
-16.09%175.61M
-8.70%933.51M
-3.05%686.61M
7.47%456.16M
8.21%209.3M
12.45%1.02B
11.78%708.18M
Administration expense
-25.57%134.47M
-11.26%118.33M
-13.69%81.63M
-13.88%41.55M
-22.28%180.65M
-20.39%133.35M
-16.22%94.58M
-13.43%48.24M
27.70%232.43M
26.36%167.51M
Financial expense
58.56%-5.58M
15.44%-7.98M
-0.08%-6.57M
-26.23%-3.26M
-66.33%-13.45M
-55.86%-9.44M
-48.45%-6.56M
-20.61%-2.58M
-233.01%-8.09M
-177.28%-6.05M
-Interest expense (Financial expense)
809.72%4.54M
286.08%489.85K
12.07%-220.65K
-1.27%-146.3K
0.00%-639K
45.07%-263.25K
21.46%-250.94K
9.57%-144.47K
-106.70%-639K
-104.95%-479.25K
-Interest Income (Financial expense)
12.22%-11.68M
7.39%-8.66M
0.39%-6.42M
-28.21%-3.13M
-79.00%-13.3M
-62.72%-9.35M
-53.12%-6.44M
-21.42%-2.44M
-81.24%-7.43M
-187.42%-5.75M
Research and development
-28.46%104.96M
-41.37%65.83M
-24.84%44.78M
-5.11%27.83M
-12.07%146.71M
-5.07%112.28M
-20.08%59.57M
-22.78%29.33M
56.05%166.86M
44.17%118.28M
Credit Impairment Loss
-400.83%-20.25M
-195.11%-11.6M
-147.10%-5.75M
--3.72M
495.26%6.73M
--12.2M
--12.2M
----
-273.14%-1.7M
----
Asset Impairment Loss
-23.66%-15.28M
---1.36M
---1.36M
----
45.95%-12.36M
----
----
----
-514.61%-22.86M
240.11%2.93M
Other net revenue
-93.21%63.16M
-94.50%51.17M
-96.90%28.42M
-96.45%18.87M
229.78%929.93M
280.51%930.04M
1,744.56%915.35M
3,766.83%532.06M
204.39%281.98M
484.43%244.42M
Fair value change income
-46.29%516.49K
---961.61K
---961.61K
---961.61K
360.64%961.61K
----
----
----
-200.00%-368.95K
--2.03M
Invest income
-90.11%91.93M
-93.31%60.96M
-96.36%32.64M
-97.34%14.1M
213.04%929.36M
307.21%911.63M
2,575.27%897.44M
4,240.60%530.76M
650.78%296.88M
514.69%223.87M
-Including: Investment income associates
95.32%89.17M
94.17%59.63M
53.98%31.54M
12.11%13.07M
-6.01%45.65M
-16.42%30.71M
-9.06%20.48M
0.84%11.66M
45.14%48.57M
58.72%36.75M
Asset deal income
-98.17%3.46K
----
----
----
108.10%189.19K
-98.58%189.61K
-98.17%194.77K
57.79%204.38K
-673.42%-2.34M
26,220,275.32%13.39M
Other revenue
23.29%6.23M
-31.34%4.14M
-30.24%3.85M
84.21%2.01M
-59.14%5.05M
173.74%6.03M
427.42%5.51M
80.64%1.09M
-73.00%12.37M
-51.51%2.2M
Operating profit
-25.36%1.37B
-46.51%879.01M
-59.35%562.5M
-70.46%289.61M
18.05%1.83B
30.44%1.64B
73.84%1.38B
142.57%980.4M
31.22%1.55B
40.10%1.26B
Add:Non operating Income
202.40%5.57M
1,234.08%1.97M
1,621.67%1.97M
2,548.55%1.95M
317.17%1.84M
-26.66%147.96K
146.04%114.4K
-75.60%73.52K
52.22%441.68K
-84.47%201.75K
Less:Non operating expense
291.70%4.76M
256.86%2.45M
-64.76%222.51K
-66.60%210.76K
-92.04%1.21M
-86.60%685.15K
-75.84%631.34K
-75.85%630.93K
-79.06%15.25M
-57.61%5.11M
Total profit
-25.34%1.37B
-46.52%878.54M
-59.21%564.25M
-70.27%291.34M
19.23%1.83B
30.91%1.64B
74.33%1.38B
143.83%979.84M
38.47%1.53B
41.25%1.25B
Less:Income tax cost
-20.07%197.97M
-50.79%118.11M
-60.57%79.16M
-72.64%40.67M
9.67%247.69M
28.25%240.01M
67.76%200.76M
128.09%148.66M
27.03%225.86M
38.43%187.14M
Net profit
-26.17%1.17B
-45.79%760.43M
-58.98%485.09M
-69.84%250.67M
20.88%1.58B
31.37%1.4B
75.50%1.18B
146.87%831.18M
40.66%1.31B
41.75%1.07B
Net profit from continuing operation
-26.29%1.17B
-46.27%754.5M
-59.51%478.95M
-70.47%245.61M
20.95%1.58B
32.11%1.4B
76.20%1.18B
146.74%831.63M
40.10%1.31B
40.34%1.06B
Net income from discontinuing operating
287.33%1.38M
455.17%5.93M
1,347.66%6.13M
1,228.41%5.07M
-524.06%-739.23K
-135.60%-1.67M
-120.62%-491.7K
-23.56%-448.9K
104.87%174.32K
211.18%4.69M
Less:Minority Profit
243.76%87.15K
347.91%276.19K
817.40%287.87K
917.99%237.21K
-117.75%-60.63K
-207.34%-111.41K
8.76%-40.13K
-205.29%-29K
-15.90%341.46K
104.23%103.79K
Net profit of parent company owners
-26.17%1.17B
-45.81%760.15M
-59.00%484.8M
-69.87%250.44M
20.92%1.58B
31.39%1.4B
75.49%1.18B
146.90%831.21M
40.69%1.31B
41.28%1.07B
Earning per share
Basic earning per share
-25.32%0.59
-45.71%0.38
-59.32%0.24
-68.29%0.13
23.44%0.79
34.62%0.7
78.79%0.59
141.18%0.41
39.13%0.64
40.54%0.52
Diluted earning per share
-25.32%0.59
-45.71%0.38
-59.32%0.24
-68.29%0.13
23.44%0.79
34.62%0.7
78.79%0.59
141.18%0.41
39.13%0.64
40.54%0.52
Other composite income
-99.49%-1.1M
-1.85%-553.17K
29.35%-543.1K
Other composite income of parent company owners
-99.49%-1.1M
----
----
----
-1.85%-553.17K
----
----
----
29.35%-543.1K
----
Total composite income
-26.21%1.17B
-45.79%760.43M
-58.98%485.09M
-69.84%250.67M
20.89%1.58B
31.37%1.4B
75.50%1.18B
146.87%831.18M
40.72%1.31B
41.75%1.07B
Total composite income of parent company owners
-26.22%1.17B
-45.81%760.15M
-59.00%484.8M
-69.87%250.44M
20.92%1.58B
31.39%1.4B
75.49%1.18B
146.90%831.21M
40.74%1.31B
41.28%1.07B
Total composite income of minority owners
243.76%87.15K
347.91%276.19K
817.40%287.87K
917.99%237.21K
-117.75%-60.63K
-207.34%-111.41K
8.76%-40.13K
-205.29%-29K
-15.90%341.46K
104.23%103.79K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
Auditor
Zhongzhu Certified Public Accountants (Special General Partnership)
--
--
--
Zhongzhu Certified Public Accountants (Special General Partnership)
--
--
--
Zhongzhu Certified Public Accountants (Special General Partnership)
--
(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021(Q9)Sep 30, 2021
Total operating revenue 10.69%3.08B-0.36%2.09B-1.53%1.37B-25.03%665.36M-14.98%2.78B-14.50%2.1B-16.53%1.39B7.85%887.48M12.99%3.27B12.33%2.46B
Operating revenue 10.69%3.08B-0.36%2.09B-1.53%1.37B-25.03%665.36M-14.98%2.78B-14.50%2.1B-16.53%1.39B7.85%887.48M12.99%3.27B12.33%2.46B
Other operating revenue 299.83%145.81M----7.32%16.63M-----25.90%36.47M----9.95%15.5M----32.54%49.22M----
Total operating cost -5.64%1.77B-8.82%1.26B-9.45%832.24M-10.14%394.62M-6.05%1.88B-3.74%1.39B0.35%919.07M1.54%439.14M10.89%2B8.39%1.44B
Operating cost -0.77%612.77M-1.64%443.41M-0.01%306.83M-0.94%149.05M7.27%617.51M2.47%450.79M1.97%306.87M5.10%150.47M-2.16%575.65M-4.60%439.91M
Operating tax surcharges -3.64%14.04M-15.54%10.39M-25.30%6.32M-12.36%3.84M29.33%14.57M3.94%12.3M12.55%8.46M1.69%4.39M-1.81%11.27M6.49%11.84M
Operating expense -2.22%912.83M-7.71%633.67M-12.48%399.25M-16.09%175.61M-8.70%933.51M-3.05%686.61M7.47%456.16M8.21%209.3M12.45%1.02B11.78%708.18M
Administration expense -25.57%134.47M-11.26%118.33M-13.69%81.63M-13.88%41.55M-22.28%180.65M-20.39%133.35M-16.22%94.58M-13.43%48.24M27.70%232.43M26.36%167.51M
Financial expense 58.56%-5.58M15.44%-7.98M-0.08%-6.57M-26.23%-3.26M-66.33%-13.45M-55.86%-9.44M-48.45%-6.56M-20.61%-2.58M-233.01%-8.09M-177.28%-6.05M
-Interest expense (Financial expense) 809.72%4.54M286.08%489.85K12.07%-220.65K-1.27%-146.3K0.00%-639K45.07%-263.25K21.46%-250.94K9.57%-144.47K-106.70%-639K-104.95%-479.25K
-Interest Income (Financial expense) 12.22%-11.68M7.39%-8.66M0.39%-6.42M-28.21%-3.13M-79.00%-13.3M-62.72%-9.35M-53.12%-6.44M-21.42%-2.44M-81.24%-7.43M-187.42%-5.75M
Research and development -28.46%104.96M-41.37%65.83M-24.84%44.78M-5.11%27.83M-12.07%146.71M-5.07%112.28M-20.08%59.57M-22.78%29.33M56.05%166.86M44.17%118.28M
Credit Impairment Loss -400.83%-20.25M-195.11%-11.6M-147.10%-5.75M--3.72M495.26%6.73M--12.2M--12.2M-----273.14%-1.7M----
Asset Impairment Loss -23.66%-15.28M---1.36M---1.36M----45.95%-12.36M-------------514.61%-22.86M240.11%2.93M
Other net revenue -93.21%63.16M-94.50%51.17M-96.90%28.42M-96.45%18.87M229.78%929.93M280.51%930.04M1,744.56%915.35M3,766.83%532.06M204.39%281.98M484.43%244.42M
Fair value change income -46.29%516.49K---961.61K---961.61K---961.61K360.64%961.61K-------------200.00%-368.95K--2.03M
Invest income -90.11%91.93M-93.31%60.96M-96.36%32.64M-97.34%14.1M213.04%929.36M307.21%911.63M2,575.27%897.44M4,240.60%530.76M650.78%296.88M514.69%223.87M
-Including: Investment income associates 95.32%89.17M94.17%59.63M53.98%31.54M12.11%13.07M-6.01%45.65M-16.42%30.71M-9.06%20.48M0.84%11.66M45.14%48.57M58.72%36.75M
Asset deal income -98.17%3.46K------------108.10%189.19K-98.58%189.61K-98.17%194.77K57.79%204.38K-673.42%-2.34M26,220,275.32%13.39M
Other revenue 23.29%6.23M-31.34%4.14M-30.24%3.85M84.21%2.01M-59.14%5.05M173.74%6.03M427.42%5.51M80.64%1.09M-73.00%12.37M-51.51%2.2M
Operating profit -25.36%1.37B-46.51%879.01M-59.35%562.5M-70.46%289.61M18.05%1.83B30.44%1.64B73.84%1.38B142.57%980.4M31.22%1.55B40.10%1.26B
Add:Non operating Income 202.40%5.57M1,234.08%1.97M1,621.67%1.97M2,548.55%1.95M317.17%1.84M-26.66%147.96K146.04%114.4K-75.60%73.52K52.22%441.68K-84.47%201.75K
Less:Non operating expense 291.70%4.76M256.86%2.45M-64.76%222.51K-66.60%210.76K-92.04%1.21M-86.60%685.15K-75.84%631.34K-75.85%630.93K-79.06%15.25M-57.61%5.11M
Total profit -25.34%1.37B-46.52%878.54M-59.21%564.25M-70.27%291.34M19.23%1.83B30.91%1.64B74.33%1.38B143.83%979.84M38.47%1.53B41.25%1.25B
Less:Income tax cost -20.07%197.97M-50.79%118.11M-60.57%79.16M-72.64%40.67M9.67%247.69M28.25%240.01M67.76%200.76M128.09%148.66M27.03%225.86M38.43%187.14M
Net profit -26.17%1.17B-45.79%760.43M-58.98%485.09M-69.84%250.67M20.88%1.58B31.37%1.4B75.50%1.18B146.87%831.18M40.66%1.31B41.75%1.07B
Net profit from continuing operation -26.29%1.17B-46.27%754.5M-59.51%478.95M-70.47%245.61M20.95%1.58B32.11%1.4B76.20%1.18B146.74%831.63M40.10%1.31B40.34%1.06B
Net income from discontinuing operating 287.33%1.38M455.17%5.93M1,347.66%6.13M1,228.41%5.07M-524.06%-739.23K-135.60%-1.67M-120.62%-491.7K-23.56%-448.9K104.87%174.32K211.18%4.69M
Less:Minority Profit 243.76%87.15K347.91%276.19K817.40%287.87K917.99%237.21K-117.75%-60.63K-207.34%-111.41K8.76%-40.13K-205.29%-29K-15.90%341.46K104.23%103.79K
Net profit of parent company owners -26.17%1.17B-45.81%760.15M-59.00%484.8M-69.87%250.44M20.92%1.58B31.39%1.4B75.49%1.18B146.90%831.21M40.69%1.31B41.28%1.07B
Earning per share
Basic earning per share -25.32%0.59-45.71%0.38-59.32%0.24-68.29%0.1323.44%0.7934.62%0.778.79%0.59141.18%0.4139.13%0.6440.54%0.52
Diluted earning per share -25.32%0.59-45.71%0.38-59.32%0.24-68.29%0.1323.44%0.7934.62%0.778.79%0.59141.18%0.4139.13%0.6440.54%0.52
Other composite income -99.49%-1.1M-1.85%-553.17K29.35%-543.1K
Other composite income of parent company owners -99.49%-1.1M-------------1.85%-553.17K------------29.35%-543.1K----
Total composite income -26.21%1.17B-45.79%760.43M-58.98%485.09M-69.84%250.67M20.89%1.58B31.37%1.4B75.50%1.18B146.87%831.18M40.72%1.31B41.75%1.07B
Total composite income of parent company owners -26.22%1.17B-45.81%760.15M-59.00%484.8M-69.87%250.44M20.92%1.58B31.39%1.4B75.49%1.18B146.90%831.21M40.74%1.31B41.28%1.07B
Total composite income of minority owners 243.76%87.15K347.91%276.19K817.40%287.87K917.99%237.21K-117.75%-60.63K-207.34%-111.41K8.76%-40.13K-205.29%-29K-15.90%341.46K104.23%103.79K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions Unqualified opinion------Unqualified opinion------Unqualified opinion--
Auditor Zhongzhu Certified Public Accountants (Special General Partnership)------Zhongzhu Certified Public Accountants (Special General Partnership)------Zhongzhu Certified Public Accountants (Special General Partnership)--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg